- Home
- SQFT vs GTBP Comparison
SQFT vs GTBP Comparison
Compare SQFT & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- GTBP
- Stock Information
- Founded
- SQFT 1999
- GTBP 1965
- Country
- SQFT United States
- GTBP United States
- Employees
- SQFT N/A
- GTBP N/A
- Industry
- SQFT Real Estate Investment Trusts
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- SQFT Real Estate
- GTBP Health Care
- Exchange
- SQFT Nasdaq
- GTBP Nasdaq
- Market Cap
- SQFT 6.2M
- GTBP 5.5M
- IPO Year
- SQFT 2020
- GTBP N/A
- Fundamental
- Price
- SQFT $5.15
- GTBP $2.26
- Analyst Decision
- SQFT
- GTBP Strong Buy
- Analyst Count
- SQFT 0
- GTBP 1
- Target Price
- SQFT N/A
- GTBP $11.00
- AVG Volume (30 Days)
- SQFT 12.4K
- GTBP 114.2K
- Earning Date
- SQFT 08-13-2025
- GTBP 08-13-2025
- Dividend Yield
- SQFT N/A
- GTBP N/A
- EPS Growth
- SQFT N/A
- GTBP N/A
- EPS
- SQFT N/A
- GTBP N/A
- Revenue
- SQFT $18,260,398.00
- GTBP N/A
- Revenue This Year
- SQFT $23.63
- GTBP N/A
- Revenue Next Year
- SQFT N/A
- GTBP N/A
- P/E Ratio
- SQFT N/A
- GTBP N/A
- Revenue Growth
- SQFT N/A
- GTBP N/A
- 52 Week Low
- SQFT $4.19
- GTBP $1.72
- 52 Week High
- SQFT $8.77
- GTBP $4.10
- Technical
- Relative Strength Index (RSI)
- SQFT 51.05
- GTBP 38.82
- Support Level
- SQFT $4.55
- GTBP $1.91
- Resistance Level
- SQFT $5.77
- GTBP $3.73
- Average True Range (ATR)
- SQFT 0.37
- GTBP 0.33
- MACD
- SQFT 0.09
- GTBP -0.16
- Stochastic Oscillator
- SQFT 56.96
- GTBP 19.59
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.